Clozapine Use in Two Full-Term Pregnancies
J Clin Psychiatry 1997;58(8):364-365 [letter]
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Letter to the Editor
Sir: The treatment of pregnant patients who have schizophrenia
is a therapeutic dilemma since all antipsychotic medications
have at least occasionally been implicated in the
development of fetal abnormalities and are classified as Pregnancy
Category C. We report the cases of two women with
treatment-resistant schizophrenia who received clozapine during
all three trimesters and delivered at term.